Back to search

France· FR:60252027

DOLOSPASMYL 60 mg/300 mg, capsule molle

A medicinal product containing citrate d'alvérine + siméticone, registered in France by LABORATOIRES MAYOLY SPINDLER.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedDOLOSPASMYL 60 mg/300 mg, capsule mol…ATC—REGISTER NO.FR:60252027PACKS LISTED4CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CITRATE D'ALVÉRINE + SIMÉTICONE
Manufacturer
LABORATOIRES MAYOLY SPINDLER
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 4

  • cip13
    3400930291443
    plaquette(s) PVC-Aluminium de 10 capsule(s)
  • cip13
    3400930036846
    plaquette(s) PVC-Aluminium de 20 capsule(s)
  • cip13
    3400930036853
    plaquette(s) PVC-Aluminium de 30 capsule(s)
  • cip13
    3400930036860
    plaquette(s) PVC-Aluminium de 40 capsule(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ade40ace-f0bf-4924-84ab-3eed203204a4
GET /v1/drugs/ade40ace-f0bf-4924-84ab-3eed203204a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60252027",
  "date_amm": "2015-10-16",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CITRATE D'ALVÉRINE + SIMÉTICONE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "capsule molle",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about citrate d'alvérine + siméticone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.